Surgical Myectomy with Anterior Mitral Leaflet Extension Versus Isolated Myectomy in Patients with Hypertrophic Obstructive Cardiomyopathy

Abstract

Background

This study evaluated the echocardiographic parameters and complication rates of surgical myectomy with concomitant anterior mitral leaflet extension (SM + AMLE) and isolated SM in hypertrophic obstructive cardiomyopathy (HOCM) patients.

Methods

All HOCM patients undergoing SM + AMLE (2006–2015) and isolated SM (2015–2020) in our centre were analysed. The primary outcome was left ventricular outflow tract (LVOT)-gradient and surgical reoperation (SM/mitral surgery). Secondary outcomes were aortic cross-clamping (ACC) time, iatrogenic ventricular septal defect (VSD), and mortality at 30-day and 3-year follow-up. Mixed-effects models assessed postoperative changes in LVOT-gradient measurements over time until a 3-year follow-up.

Results

This cohort (n = 59) consisted of 34 (58%) SM + AMLE and 25 (42%) isolated SM procedures. There were 32 (54%) males and 27 (46%) females with a mean age of 55 ± 13 years at the time of the intervention. Postoperatively, no differences were observed over time in the median LVOT-gradient (p = 0.34). In the SM + AMLE group, 6% (n = 2) required surgical reoperation (due to patch dehiscence) versus 0% in the SM group. In the SM + AMLE group, the ACC time was significantly higher (86 minutes [interquartile range [IQR]: 74–103]) than in the isolated SM group (48 minutes [IQR: 39–57]; p < 001). In both groups, the VSD complication rate was 0%, and neither procedure led to death at 3-year follow-up.

Conclusion

HOCM-patients who underwent SM + AMLE had comparable clinical and echocardiographic outcomes to patients who underwent isolated SM. This suggests that increasing procedural complexity may not improve outcomes. However, given potential confounding, this should be interpreted with caution, future prospective randomised controlled trials are necessary.

Keywords

cardiomyopathy - mitral valve surgery - surgery - complications

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Informed Consent

All patients provided written informed consent.

Publication History

Received: 10 July 2025

Accepted: 08 December 2025

Accepted Manuscript online:
11 December 2025

Article published online:
07 January 2026

• References

• 1 Arbelo E, Protonotarios A, Gimeno JR. et al; ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023; 44 (37) 3503-3626
• 2 Guigui SA, Torres C, Escolar E, Mihos CG. Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review. J Thorac Dis 2022; 14 (06) 2309-2325
• 3 Kotkar KD, Said SM, Dearani JA, Schaff HV. Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience. Ann Cardiothorac Surg 2017; 6 (04) 329-336
• 4 Nguyen A, Schaff HV, Ommen SR. et al. Late health status of patients undergoing myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg 2021; 111 (06) 1867-1875
• 5 Heeringa TJP, Hegeman RMJJ, Koop Y. et al; SAM-Registry Study Investigators, Cardiothoracic Surgery Registration Committee of the Netherlands. Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes. Eur Heart J 2025; ehaf560
• 6 Alashi A, Smedira NG, Hodges K. et al. Outcomes in guideline-based class I indication versus earlier referral for surgical myectomy in hypertrophic obstructive cardiomyopathy. J Am Heart Assoc 2021; 10 (01) e016210
• 7 Vriesendorp PA, Schinkel AFL, Soliman OII. et al. Long-term benefit of myectomy and anterior mitral leaflet extension in obstructive hypertrophic cardiomyopathy. Am J Cardiol 2015; 115 (05) 670-675
• 8 Ommen SR, Mital S, Burke MA. et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2020; 142 (25) e558-e631
• 9 Kofflard MJ, van Herwerden LA, Waldstein DJ. et al. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1996; 28 (01) 197-202
• 10 Morrow AG, Reitz BA, Epstein SE. et al. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation 1975; 52 (01) 88-102
• 11 Pinheiro JC, Bates DM. Mixed-Effects Models in S and S-PLUS. New York: Springer-Verlag; 2000
• 12 Akins CW, Miller DC, Turina MI. et al; STS, AATS, EACTS. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg 2008; 85 (04) 1490-1495
• 13 Hodges K, Rivas CG, Aguilera J. et al. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. J Thorac Cardiovasc Surg 2019; 157 (06) 2289-2299
• 14 Collis R, Watkinson O, O'Mahony C. et al. Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Eur J Heart Fail 2018; 20 (02) 398-405
• 15 Desai MY, Bhonsale A, Smedira NG. et al. Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction. Circulation 2013; 128 (03) 209-216
• 16 Hong JH, Nguyen A, Schaff HV. Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy. Indian J Thorac Cardiovasc Surg 2020; 36 (Suppl. 01) 34-43
• 17 Hong JH, Schaff HV, Nishimura RA. et al. Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures. J Am Coll Cardiol 2016; 68 (14) 1497-1504
• 18 Holst KA, Hanson KT, Ommen SR, Nishimura RA, Habermann EB, Schaff HV. Septal myectomy in hypertrophic cardiomyopathy: national outcomes of concomitant mitral surgery. Mayo Clin Proc 2019; 94 (01) 66-73
• 19 van der Lee C, Kofflard MJM, van Herwerden LA, Vletter WB, ten Cate FJ. Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy. Circulation 2003; 108 (17) 2088-2092
• 20 Huurman R, Schinkel AFL, de Jong PL, van Slegtenhorst MA, Hirsch A, Michels M. Impact of sex on timing and clinical outcome of septal myectomy for obstructive hypertrophic cardiomyopathy. Int J Cardiol 2021; 323: 133-139
• 21 Lentz Carvalho J, Schaff HV, Nishimura RA. et al. Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy?. J Thorac Cardiovasc Surg 2023; 165 (01) 79-87.e1